HomeCompareTYBS vs JNJ

TYBS vs JNJ: Dividend Comparison 2026

TYBS yields 14.45% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TYBS wins by $31.6K in total portfolio value
10 years
TYBS
TYBS
● Live price
14.45%
Share price
$13.84
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$51.6K
Annual income
$3,533.87
Full TYBS calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — TYBS vs JNJ

📍 TYBS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTYBSJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TYBS + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TYBS pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TYBS
Annual income on $10K today (after 15% tax)
$1,228.32/yr
After 10yr DRIP, annual income (after tax)
$3,003.79/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, TYBS beats the other by $2,300.18/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TYBS + JNJ for your $10,000?

TYBS: 50%JNJ: 50%
100% JNJ50/50100% TYBS
Portfolio after 10yr
$35.8K
Annual income
$2,180.83/yr
Blended yield
6.09%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

TYBS
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TYBS buys
0
JNJ buys
0
No recent congressional trades found for TYBS or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTYBSJNJ
Forward yield14.45%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$51.6K$20.0K
Annual income after 10y$3,533.87$827.78
Total dividends collected$24.4K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: TYBS vs JNJ ($10,000, DRIP)

YearTYBS PortfolioTYBS Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$12,145$1,445.09$10,676$355.77+$1.5KTYBS
2$14,635$1,640.25$11,407$389.39+$3.2KTYBS
3$17,507$1,847.28$12,198$426.53+$5.3KTYBS
4$20,798$2,065.19$13,056$467.62+$7.7KTYBS
5$24,547$2,292.87$13,987$513.12+$10.6KTYBS
6$28,794$2,529.11$14,998$563.56+$13.8KTYBS
7$33,582$2,772.65$16,098$619.52+$17.5KTYBS
8$38,955$3,022.16$17,295$681.69+$21.7KTYBS
9$44,958$3,276.34$18,599$750.82+$26.4KTYBS
10$51,639$3,533.87$20,022$827.78+$31.6KTYBS

TYBS vs JNJ: Complete Analysis 2026

TYBSStock

The investment seeks daily investment results, before fees and expenses, of 100% of the inverse (or opposite) of the daily performance of the ICE U.S. Treasury 20+ Year Bond Index. The fund, under normal circumstances, invests in swap agreements, futures contracts, short positions or other financial instruments that, in combination, provide inverse (opposite) or short exposure to the index equal to at least 80% of the fund&#39;s net assets (plus borrowing for investment purposes). The index is a market value weighted index that includes publicly issued U.S. Treasury securities that have a remaining maturity of greater than 20 years. The fund is non-diversified.

Full TYBS Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this TYBS vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TYBS vs SCHDTYBS vs JEPITYBS vs OTYBS vs KOTYBS vs MAINTYBS vs ABBVTYBS vs MRKTYBS vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.